Moiseyev Gilad 4
4 · Brainsway Ltd. · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Brainsway (BWAY) CTO Gilad Moiseyev Exercises Options and Sells Shares
What Happened
Gilad Moiseyev, Chief Technology Officer of Brainsway Ltd. (BWAY), exercised options to acquire 7,500 ordinary shares on May 25, 2026. The company withheld 1,902 shares to cover exercise price/taxes. Moiseyev later sold 5,000 shares in an open-market transaction on June 15, 2026 at NIS 42.0397 per share (total proceeds ≈ NIS 210,198.50). The option exercise price was NIS 11.17 per share. Based on the reported transactions, about 598 shares remain from this exercise (7,500 exercised − 1,902 withheld − 5,000 sold), plus any previously held shares and unvested awards.
Key Details
- Transaction dates: May 25, 2026 (exercise and withholding) and June 15, 2026 (open-market sale).
- Exercise price: NIS 11.17 per share (footnote F2).
- Withheld/retained shares: 1,902 shares were retained by the company in payment of exercise price/taxes; the company retained shares at NIS 44.04 per share per the filing (footnote F4).
- Sale price: NIS 42.0397 per share for the 5,000-share sale (footnote F5).
- Net shares from this exercise: approximately 598 remaining (calculated from reported acquisition, withholding and sale).
- Holdings after transaction: the filing does not list a single consolidated total; it does detail unvested RSUs and remaining options (see Context).
- Timeliness: The Form 4 was filed June 22, 2026 for transactions starting May 25 and June 15 — this appears later than the typical two-business-day filing window for Form 4s.
Context
- These were option exercises (derivative transactions). The company’s retention of shares to cover exercise price/taxes indicates a sell-to-cover/net exercise rather than an all-cash exercise.
- The filing includes details on other equity awards: unvested RSUs to receive 6,563; 10,000; and 27,500 ordinary shares with staggered vesting schedules (footnote F3). Stock options granted March 5, 2024 remain outstanding, with 13,125 options vesting in equal quarterly installments through March 5, 2028 (footnote F6).
- Facts only — no inference about the insider’s view of the company’s prospects is made.
Insider Transaction Report
Form 4
Brainsway Ltd.BWAY
Moiseyev Gilad
Chief Technology Officer
Transactions
- Exercise/Conversion
Ordinary Shares
[F1][F2][F3]2026-05-25+7,500→ 60,000 total - Tax Payment
Ordinary Shares
[F1][F4][F3]2026-05-25−1,902→ 58,098 total - Sale
Ordinary Shares
[F1][F5][F3]2026-06-15−5,000→ 53,098 total - Exercise/Conversion
Stock Options (right to buy)
[F2][F6][F1]2026-05-25−7,500→ 22,500 totalExp: 2034-03-05→ Ordinary Shares (7,500 underlying)
Footnotes (6)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The exercise price is NIS 11.17 per share.
- [F3]This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
- [F4]These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.
- [F5]The sale price was NIS 42.0397 per share.
- [F6]Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.
Signature
/s/ Gilad Moiseyev|2026-06-22